*Storage: Keep in dark place,Inert atmosphere,2-8°C.
*Shipping: Normal
4.5
*For research use only!
Change View
Size | Price | USA Stock *0-1 Day | Global Stock *5-7 Days | In Stock |
100mg | łËó¶Ê | In Stock | In Stock | Login |
250mg | ł§Í¶Ê | In Stock | In Stock | Login |
1g | łďď¶Ê | In Stock | In Stock | Login |
5g | łËÇË¶Ê | Inquiry | In Stock | Login |
Please Login or Create an Account to: See VIP prices and availability
łËó¶Ê
ł§Í¶Ê
łďď¶Ê
łËÇ˶Ê
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 52537-00-5 |
Formula : | C8H8ClN |
M.W : | 153.61 |
MDL No. : | MFCD07371639 |
Boiling Point : | No data available |
InChI Key : | HSLNYVREDLDESE-UHFFFAOYSA-N |
Pubchem ID : | 258567 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H317 |
Precautionary Statements: | P280 |
Num. heavy atoms | 10 |
Num. arom. heavy atoms | 6 |
Fraction Csp3 | 0.25 |
Num. rotatable bonds | 0 |
Num. H-bond acceptors | 0.0 |
Num. H-bond donors | 1.0 |
Molar Refractivity | 46.54 |
TPSA ? Topological Polar Surface Area: Calculated from | 12.03 Ų |
Log Po/w (iLOGP)? iLOGP: in-house physics-based method implemented from | 1.88 |
Log Po/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by | 2.72 |
Log Po/w (WLOGP)? WLOGP: Atomistic method implemented from | 1.74 |
Log Po/w (MLOGP)? MLOGP: Topological method implemented from | 2.33 |
Log Po/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by | 2.86 |
Consensus Log Po/w? Consensus Log Po/w: Average of all five predictions | 2.3 |
Log S (ESOL):? ESOL: Topological method implemented from | -2.95 |
Solubility | 0.172 mg/ml ; 0.00112 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (Ali)? Ali: Topological method implemented from | -2.63 |
Solubility | 0.363 mg/ml ; 0.00236 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by | -3.6 |
Solubility | 0.0387 mg/ml ; 0.000252 mol/l |
Class? Solubility class: Log S scale | Soluble |
GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg | High |
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg | Yes |
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) | No |
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) | Yes |
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) | No |
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) | No |
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) | No |
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) | No |
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from | -5.31 cm/s |
Lipinski? Lipinski (Pfizer) filter: implemented from | 0.0 |
Ghose? Ghose filter: implemented from | None |
Veber? Veber (GSK) filter: implemented from | 0.0 |
Egan? Egan (Pharmacia) filter: implemented from | 0.0 |
Muegge? Muegge (Bayer) filter: implemented from | 2.0 |
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat | 0.55 |
PAINS? Pan Assay Interference Structures: implemented from | 0.0 alert |
Brenk? Structural Alert: implemented from | 0.0 alert: heavy_metal |
Leadlikeness? Leadlikeness: implemented from | No; 1 violation:MW<1.0 |
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) | 1.33 |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | Example 19 6-Chloro-1-(3-pyridylcarbamoyl)indoline (E19) The title compound was prepared as in the method of (Example 2) from 3-pyridylisocyanate and <strong>[52537-00-5]6-chloroindoline</strong> (D36) to give (E19) (1.54 g, 73%) m.p. 204-5 C. NMR (DMSO-d6) delta: 3.19 (2H, t, J=8), 4.19 (2H, t, J=8), 6.93-6.99 (1H, m), 7.23 (1H, d, J=8), 7.31-7.38 (1H, m), 7.88 (1H, s), 7.94-8.02 (1H, m), 8.24 (1H, d, J=6), 8.72 (1H, s), 8.82 (1H, s). Found: C, 61.34; H, 4.60; N, 15.38 C14 H12 N3 OCl requires: C, 61.43; H, 4.42; N, 15.35 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With sodium cyanoborohydride; acetic acid; at 20℃; for 0.333333h; | Reduction of Indoles to Indolines:; PREPARATION 142; 6-Chloro-2, 3-dihydro-lH-indole; Dissolve 6-chloro-lH-indole (2 g, 0.013 mol) in acetic acid (10 mL) under nitrogen. Add sodium cyanoborohydride (1.24 g, 1.5 eq) and stir 20 minutes at room temperature. Dilute with ethyl acetate and extract with sodium hydroxide (5 N aqueous). Dry over magnesium sulfate, filter and concentrate to give 2.35 g (116%) crude product. MS (ES, m/z) : 154.0 (M+1). |
87% | 6-chloro-2,3-dihydro-1H-indole Under a nitrogen atmosphere 0.50 g (7.9 mmol) sodium cyanoborohydride were added batchwise to 1.0 g (6.6 mmol) 5-hydroxyindole in 5.0 mL glacial acetic acid and the mixture was stirred for 60 min at RT. Then the reaction mixture was poured onto a 4N aqueous sodium hydroxide solution and extracted with EtOAc. The combined organic phases were washed several times with saturated sodium hydrogen carbonate solution, dried on sodium sulphate and evaporated down. Yield: 1.1 g (87% of theoretical) Rt (HPLC-MS): 1.24 min (method C) | |
87% | With sodium cyanoborohydride; acetic acid; at 20℃; for 3h; | Synthesis of In acetic acid (2.0 mL) solution of 6-chloro -1H- indole (200 mg, 1.3 mmol), sodium cyanoborohydride (170 mg, 2.6 mmol) was added at room temperature,and was stirred at 3 hours. It added 1 N aqueous sodium hydroxide to the reaction mixture (30 mL) at room temperature, followed by extraction with ethyl acetate (30 mL). The organic layer was dried over sodium sulfate, and concentratedIt was. The resulting concentrate was purified by silica gel column chromatography is purified by (eluent ethyl acetate / n-hexane = 25/75), 6-chloro-indoline as a colorless oilObtained (180mg, 87% yield). |
86% | Preparation 30: 6-Chloro-2,3-dihydro-1 H-indole6-Chloroindole (1.0 g, 6.6 mmol) was dissolved in a solution of borane in THF (1 M, 9.83 mmol) at 0 C and stirred for 30 min. TFA (9.83 mL) was added dropwise and the solution stirred at 0 C for 30 min. 6 M aqueous NaOH was added until the solution was basic (pH 1 1 ). The aqueous solution was extracted with DCM (3 x 25 mL), dried over sodium sulfate, filtered and concentrated to give the title compound (864 mg, 86%) as a yellow oil. 1H NMR (Me-d3-OD): 6.99 (1 H, d), 6.64-6.55 (2H, m), 3.50 (2H, t), 2.95 (2H, t). | |
72% | With sodium cyanoborohydride; for 22h; | In a 250 mL round bottom flask, 12.4 grams of sodium cyanoborohydride (198 mmol, 2 eq. ) were added potion-wise over 5 minutes to a solution of 15 grams (98.9 mmol) of 6-chloroindole. After stirring for 22 hours, the mixture had become a brown solution and analysis by [HPLC] (MRH 1 method) revealed no starting material remaining and a mixture of two product peaks. The mixture was diluted with 100 [ML] of water, then made basic [WITH-200] mL of 6N sodium hydroxide. The desired product was extracted into 3 X 400 mL of methylene chloride. The extracts were then dried over anhydrous magnesium sulfate and evaporated in vacuo leaving a cloudy oil. The crude product was chromatographed over a plug of silica in 100 % methylene chloride giving a mixed fraction [(RF=] 0.9 and 0.7), a pure product fraction [(RF= 0. 7),] and a baseline fraction (Rf = 0.0-0. 2). The pure fraction was evaporated to dryness in vacuo to yield a clear, colorless oil weighing 10.90 grams (72 %). It was stored at [4C] and saved for future [USE. 1H] NMR (300 MHz, DMSO-d6) 8 6.95 (d, J= 5 Hz, 1 H), 6.46 (d, [J=] 5 Hz, 2 H), 3.43 (t, [J=] 6,2 H), 2.86 (t, [J=] 6,2 H). |
With sodium cyanoborohydride; In acetic acid; at 20℃; for 1h; | [0278] 6-Chloroindole (1 g, 6.6 mmol) in glacial acetic acid (10 mL) was treated with sodium cyanoborohydride (829 mg, 13.2 mmol) portionwise at room temperature with stirring. After 1 hour, the reaction was diluted with water (25 mL) and basified with 40% sodium hydroxide with cooling. The mixture was then extracted with dichloromethane (3×50 mL), dried and concentrated to give 1 g of 6-chloroindoline. It was used in the next step without further purification. 1HNMR (300 MHz, dimethylsulfoxide-d6) delta 6.95 (d, 1H), 6.46 (dd, 1H), 6.43 (d, 1H), 5.74 (br s, 1H, NH), 3.42 (t, 2H, CH2), 2.85 (t, 2H, CH2). MS m/z 349 [M+1]. | |
EXAMPLE 208a Preparation of intermediate 6-chloro-2,3-dihydro-1H-indole Sodium borohydride (2.0 g, 53 mmol) (Aldrich) was added in small portions to a mixture of 6-chloro-1H-indole (1.0 g, 6.6 mmol) (Aldrich) in TFA (10 mL), which was cooled in ice-water bath, at such a rate that gas evolution was not too vigorous. When the addition was complete, the mixture was allowed to warm to room temperature and stirred overnight. The resulting mixture was concentrated in vacuo and the residue was dissolved in DCM. The organic layer was washed with Na2CO3 solution, dried with Na2SO4, and concentrated to give 0.6 g crude 6-chloro-2,3-dihydro-1H-indole. MS: [M+H]+=154 | ||
16%Chromat. | With 6C53H32O8(4-)*13Zr(4+)*18O(2-)*8Co(2+)*8Cl(1-); hydrogen; sodium triethylborohydride; In toluene; at 80℃; under 30003.0 Torr; for 72h; | General procedure: At a 0.5 mol % Co loading, Zr-MTBC-CoH catalyzed hydrogenation of indole in toluene at 80 C. to afford a mixture of indoline and 4,5,6,7-tetrahydroindole. Indoline was obtained in 84% isolated yield after preparative TLC. See first entry, Table 19, below. Hydrogenation of 3-methyl-indole gave 3-methyl-indoline and 3-methyl-4,5,6,7-tetrahydroindole in 46:54 ratio, which indicates that reduction of the phenyl ring is also possible. Hydrogenation of quinolines in toluene at 80 C. gave a mixture of two products, 1,2,3,4-tetrahydroquinoline and 5,6,7,8-tetrahydro-quinoline in a 1:1 ratio. Under identical reaction conditions, the selectivity appears dependent on the substitution of the phenyl ring. Electron-donating substituents at the 6-position of the quinolines favor the hydrogenation of the phenyl ring. For example, the 6-methylquinoline, 6-methoxyquinoline and 2,6-dimethylquinoline were hydrogenated to give 6-methyl-5,6,7,8-tetrahydro-quinoline, 6-methoxy-5,6,7,8-tetrahydro-quinoline and 2,6-dimethyl-5,6,7,8-tetrahydro-quinoline, respectively, as the major products. See Table 19. In contrast, strong electron-withdrawing substituents seem to disfavor the reduction of the phenyl ring. The hydrogenation of 2-methyl-6-fluoro-quinoline afforded 2-methyl-6-fluoro-1,2,3,4,-tetrahydro-quinoline exclusively in 72% yield. See second to last entry, Table 19. Zr-MTBC-CoH was also an active catalyst for hydrogenation of benzofuran. At a 0.2 mol % Co loading, benzofuran was completely hydrogenated to 2,3-dihydrobenzofuran in qualitative yield. See next to last entry, Table 19. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20.1% | A mixture of tert-butyl 2-(4-amino-2-(4-bromo-l-methyl-lH-pyrazol-5-yl)rhohenoxy) ethylcarbamate (30 mg, 54 mumol) and <strong>[52537-00-5]6-chloroindoline</strong> (8.3 mg, 54 mumol) in ImL of DMF was <n="179"/>stirred at room temperature overnight. Then to the mixture was added 1 mL of 2M HCl. The mixture was stirred at room temperature overnight. The mixture was concentrated and the crude product was subjected to purification on HPLC. The proper fractions were collected and lyophilized to afford yellow oil in 20.1 % yield. LCMS m/z (%) = 492 (M+H 35Cl 79Br, 100). 1H NMR (400 MHz, MeOD) delta ppm 3.1 (m, 4 H), 3.7 (s, 3 H)3 4.1 (m, 3 H), 4.2 (m, 1 H), 6.8 (dd, J=7.6, 2.0 Hz, 1 H), 7.1 (d, 3=7.6 Hz, 1 H), 7.1 (d, J=9.1 Hz, 1 H), 7.3 (d, J=3.0 Hz, 1 H), 7.5 (s, 1 H), 7.6 (dd, J=9.1, 2.5 Hz, 1 H)5 7.8 (d, J=2.0 Hz, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | EXAMPLE 208b Preparation of rac-6,6'-Dichloro-3'-(3-chloro-benzyl)-2,3,1',3'-tetrahydro-[1,3']biindolyl-2'-one The mixture of rac-3-bromo-6-chloro-3-(3-chloro-benzyl)-1,3-dihydro-indol-2-one (100 mg, 0.27 mmol) (from example 1c supra), <strong>[52537-00-5]6-chloro-2,3-dihydro-1H-indole</strong> (62 mg, 0.45 mmol) and K2CO3 (110 mg, 0.80 mmol) in DMF (1 mL) was stirred at room temperature overnight. Then water (10 mL) was added and the desired product was precipitated out. The crude product was purified by prep-HPLC to give 55 mg rac-6,6'-Dichloro-3'-(3-chloro-benzyl)-2,3,1',3'-tetrahydro-[1,3']biindolyl-2'-one. MS: [M+H]+=443 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | With sodium cyanoborohydride; In acetic acid; for 10h; | Sodium cyanoborohydride (4. [88] g, 77.8 mmol) was added to a solution of 6- chloroindoline (5.9 g, [38.] 9 mmol) in acetic acid (100 mL). Gas evolution was evident at the beginning of the reaction. After stirring for 10 h, the solution was diluted with water (100 mL) and 6 N [NAOH] was added until the pH of the reaction mixture was 12-13. The resulting mixture was extracted with [CH2CLZ] (3 x 200 mL), and the combined organic layers dried over [MGS04.] Flash column chromatography on silica gel (35% [ETOAC/HEXANES)] yielded 2.3 g (39%) of a clear liquid : 1H NMR (DMSO-d6) 8 2.87 (t, J= 8.4 Hz, 2H), 3.44 (t, [J =] 8.4 Hz, 2H), 6.45 (d, J= 1.8 Hz, 1H), 6.47 (dd, J = 1.8, 7.6 Hz, 1H), 6.96 (d, J = 7.3 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In 4,5,8,9,10,1-Hexahydro-7H-azepino[4,5-b]pyrrolo[3,2,1-hi]indole Hydrochloride; | EXAMPLE 40 Preparation of 1-Chloro-4,5,8,9,10,11-hexahydro-7H-azepino[4,5-b]pyrrolo[3,2,1-hi]indole Maleic Acid Following the general procedure outlined in EXAMPLE 14, and making non-critical variations but starting with <strong>[52537-00-5]6-chloro-indoline</strong>, the title compound was obtained (amorphous solid). 1H NMR (CD3OD) 6.91, 6.81, 6.77, 4.90, 3.69, 3.34, 3.21; MS (ESI+) for C14H15ClN2 m/z 247.2 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; In dichloromethane; N,N-dimethyl-formamide; | EXAMPLE 37 4-(6-Chloro-2,3-dihydro-indol-1-yl)-pyrido[3,4-d ]pyrimidine 4-Chloropyrido[3,4-d]pyrimidine (0.10 g, 0.60 mmol), <strong>[52537-00-5]6-chloroindoline</strong> (0.10 g, 0.66 mmol) and pyridine (0.14 g, 1.81 mmol) were combined in DMF (1 mL) and heated at 70 C. for 3 hours. The reaction was cooled to room temperature and then added to methylene chloride (150 mL). The organic layer was washed with saturated sodium carbonate and water and then dried over sodium sulfate. The solvent was removed by rotary evaporation and the residue purified by column chromatography (silica gel, 9/2/1-CH2Cl2/hexanes/methanol) to give the title product as a pale yellow residue (0.048 g, 28%). MP 194-6 C.; LCMS: 283 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; In dichloromethane; N,N-dimethyl-formamide; | EXAMPLE 28 4-(6-Chloro-2,3-dihydro-indol-1-yl)-pyrido[3,4-d]pyrimidine 4-Chloropyrido[3,4]pyrimidine (0.10 g, 0.60 mmol), <strong>[52537-00-5]6-chloroindoline</strong> (0.10 g, 0.66 mmol) and pyridine (0.14 g, 1.81 mmol) were combined in DMF (1 mL) and heated at 70 C. for 3 hr. The reaction was cooled to room temperature and then added to methylene chloride (150 mL). The organic layer was washed with saturated sodium carbonate and water and then dried over sodium sulfate. The solvent was removed by rotary evaporation and the residue purified by column chromatography (silica gel, 9/2/1-CH2Cl2/hexanes/methanol) to give a pale yellow residue (0.048 g, 28%). MP 194-6 C.; LCMS: 283 (MH+). The products of examples 29-31 were prepared according to the method of Example 1 from 4-chloropyrido[3,4-d]pyrimidine (1 eq.) and the indicated amine. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | With ammonium acetate; In acetonitrile; | EXAMPLE 76 4-(6-Chloro-2,3-dihydro-indol-1-yl)-6-methyl-pyrido[3,4-d]pyrimidine This material was produced from 4-chloro-6-methyl-pyrido[3,4-d]pyrimidine (1.0 eq.) and <strong>[52537-00-5]6-chloroindoline</strong> (1.1 eq.) as described for Example 74. Preparative reversed-phase (C18) chromatography utilizing a gradient of 15% to 70% acetonitrile/pH4.5, 50 mM ammonium acetate followed by lyophilization of the appropriate fractions afforded the title product (30%) (M.P. 232-234 C.; LC-MS: 297 (MH+); anal.RP-HPLC:4.33 min.). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
EXAMPLE 8 4-(6-Chloro-2,3-dihydroindol-1-yl)-6-(4-nitro-phenyl)-7H-pyrrolo[2,3-d]-pyrimidine This product is prepared in a manner analogous to that described in Example 6 from 4-chloro-6-(4-nitro-phenyl)-7H-pyrrolo[2,3-d]pyrimidine and <strong>[52537-00-5]6-chloro-2,3-dihydroindole</strong> (1.1 equivalents). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
EXAMPLE 2 4-(6-Chloro-2.3-dihydroindol-1-yl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidine This product is prepared in a manner analogous to that described in Example 1 from 4-chloro-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidine and <strong>[52537-00-5]6-chloro-2,3-dihydroindole</strong> (1.1 equi-valents, see J. Org. Chem. 55(2), 580-584 (1990); CAS Reg. No. 52 537-00-5). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74.9% | With sodium cyanoborohydride; acetic acid; at 25℃; for 1h; | General procedure: At 25 , 5-methoxy-indole (1.5g, 10.2mmol) was added to acetic acid (20 mL), and then added portionwise sodium cyanoborohydride (0.77g, 12.2mmol), 1 hour reaction, was added sodium hydroxide solution (20%) neutralized to pH = 9 ~ 10, then ethyl acetate (50 mL) and extracted, the organic phase after separation was dried over anhydrous sodium sulfate. Filtered, the filtrate was spin dry, purified by column chromatography (petroleum ether / ethyl acetate (v / v) = 10/1) to give the title compound as a brown solid (1.46g, 95.9%). |
Preparation 39 6-Chloro-indoline This material was conveniently prepared on multigram scale from the cyclization of 2,4-dichlorophenethylamine in the presence of Na2 CO3 (s)(s) (1.2 mol eq), Cu2 Cl2 (0.01 mol eq) and 8-hydroxyquinoline (0.012 mol eq) in isoamyl alcohol (1 vol) at 130 C. for 5 hours. After addition of hydrazine (0.0055 vol) and 1 hour reflux, the mixture was filtered, solvent was removed in vacuo (45 C. a ~10 mm Hg) and 6-chloro-indoline was obtained pure by vacuum distillation (95-100 C. a 2 mm Hg)(65-95%). | ||
4.21 g (31.57 mmol*1.05 equivalents) of chloropropionyl chloride in 40 ml of acetone were added at room temperature to a solution of 4.85 g (31.57 mmol) of 6-chloroindoline ?prepared as described in step (5) above! in acetone, and the mixture was heated under reflux for 2 hours. At the end of this time, the reaction mixture was poured into 10% w/v aqueous hydrochloric acid, and the solids which precipitated were collected by filtration. The filtrate was extracted with ethyl acetate and washed with water, after which it was dried over anhydrous magnesium sulfate. The mixture was filtered, and then the solvent was removed by distillation under reduced pressure, and the residue was dissolved in a small amount of ethyl acetate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | In isopropyl alcohol; | Example 64 4-(6-Chloro-2,3-dihydro-indol-1-yl)-7-methoxy-quinazoline hydrochloride salt Utilizing a procedure analogous to that described in Example 1 (with conversion to the HCl salt as outlined for Example 2), this product was prepared in 82% yield from <strong>[52537-00-5]6-chloro-indoline</strong> (1.1 eq.), and 4-chloro-7-methoxy-quinazoline (1.0 eq) in i-PrOH. (M.P. of free-base: 140-141 C.; For HCl salt: M.P. 232-233 C.; LC-MS: 312 (MH+); anal. RP18-HPLC RT: 5.68 min.). |
Tags: 52537-00-5 synthesis path| 52537-00-5 SDS| 52537-00-5 COA| 52537-00-5 purity| 52537-00-5 application| 52537-00-5 NMR| 52537-00-5 COA| 52537-00-5 structure
A105462[ 90562-34-8 ]
7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride
Similarity: 0.94
A305343[ 90562-35-9 ]
7-Chloro-1,2,3,4-tetrahydroquinoline
Similarity: 0.94
A232735[ 1210734-76-1 ]
4,6-Dichloroindoline hydrochloride
Similarity: 0.89
A364949[ 1783400-57-6 ]
6,7-Dichloro-1,2,3,4-tetrahydroquinoline
Similarity: 0.89
A232735[ 1210734-76-1 ]
4,6-Dichloroindoline hydrochloride
Similarity: 0.89
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL